世界の注射式駆虫薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Injectable Anthelmintic Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4371
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、注射式駆虫薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ベンズイミダゾール、ピペラジン、イミダゾチアゾール、スピロインドール、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、動物用薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・注射式駆虫薬の市場動向
・企業の競争状況、市場シェア
・注射式駆虫薬の種類別市場規模と予測2016-2027（ベンズイミダゾール、ピペラジン、イミダゾチアゾール、スピロインドール、その他）
・注射式駆虫薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局、動物用薬局、その他）
・注射式駆虫薬の北米市場規模2016-2027（アメリカ、カナダ）
・注射式駆虫薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・注射式駆虫薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・注射式駆虫薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・注射式駆虫薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novartis、Cipla、Sun Pharmaceutical Industries、Amneal Pharmaceuticals、Zoetis、GlaxoSmithKline、Bayer、Merck、Boehringer Ingelheim International）
・結論

Market Analysis and Insights: Global Injectable Anthelmintic Drugs Market
The global Injectable Anthelmintic Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Injectable Anthelmintic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Injectable Anthelmintic Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Injectable Anthelmintic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Injectable Anthelmintic Drugs market.

Global Injectable Anthelmintic Drugs Scope and Market Size
Injectable Anthelmintic Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Injectable Anthelmintic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Benzimidazoles
Piperazine
Imidazothiazole
Spiroindoles
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Veterinary Pharmacies
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis
Cipla
Sun Pharmaceutical Industries
Amneal Pharmaceuticals
Zoetis
GlaxoSmithKline
Bayer
Merck
Boehringer Ingelheim International

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Benzimidazoles
1.2.3 Piperazine
1.2.4 Imidazothiazole
1.2.5 Spiroindoles
1.2.6 Others
1.3 Market by Application
1.3.1 Global Injectable Anthelmintic Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Veterinary Pharmacies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Injectable Anthelmintic Drugs Market Perspective (2016-2027)
2.2 Injectable Anthelmintic Drugs Growth Trends by Regions
2.2.1 Injectable Anthelmintic Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Injectable Anthelmintic Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Injectable Anthelmintic Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Injectable Anthelmintic Drugs Industry Dynamic
2.3.1 Injectable Anthelmintic Drugs Market Trends
2.3.2 Injectable Anthelmintic Drugs Market Drivers
2.3.3 Injectable Anthelmintic Drugs Market Challenges
2.3.4 Injectable Anthelmintic Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Injectable Anthelmintic Drugs Players by Revenue
3.1.1 Global Top Injectable Anthelmintic Drugs Players by Revenue (2016-2021)
3.1.2 Global Injectable Anthelmintic Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Injectable Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Injectable Anthelmintic Drugs Revenue
3.4 Global Injectable Anthelmintic Drugs Market Concentration Ratio
3.4.1 Global Injectable Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Injectable Anthelmintic Drugs Revenue in 2020
3.5 Injectable Anthelmintic Drugs Key Players Head office and Area Served
3.6 Key Players Injectable Anthelmintic Drugs Product Solution and Service
3.7 Date of Enter into Injectable Anthelmintic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Injectable Anthelmintic Drugs Breakdown Data by Type
4.1 Global Injectable Anthelmintic Drugs Historic Market Size by Type (2016-2021)
4.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2022-2027)

5 Injectable Anthelmintic Drugs Breakdown Data by Application
5.1 Global Injectable Anthelmintic Drugs Historic Market Size by Application (2016-2021)
5.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Injectable Anthelmintic Drugs Market Size (2016-2027)
6.2 North America Injectable Anthelmintic Drugs Market Size by Type
6.2.1 North America Injectable Anthelmintic Drugs Market Size by Type (2016-2021)
6.2.2 North America Injectable Anthelmintic Drugs Market Size by Type (2022-2027)
6.2.3 North America Injectable Anthelmintic Drugs Market Size by Type (2016-2027)
6.3 North America Injectable Anthelmintic Drugs Market Size by Application
6.3.1 North America Injectable Anthelmintic Drugs Market Size by Application (2016-2021)
6.3.2 North America Injectable Anthelmintic Drugs Market Size by Application (2022-2027)
6.3.3 North America Injectable Anthelmintic Drugs Market Size by Application (2016-2027)
6.4 North America Injectable Anthelmintic Drugs Market Size by Country
6.4.1 North America Injectable Anthelmintic Drugs Market Size by Country (2016-2021)
6.4.2 North America Injectable Anthelmintic Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Injectable Anthelmintic Drugs Market Size (2016-2027)
7.2 Europe Injectable Anthelmintic Drugs Market Size by Type
7.2.1 Europe Injectable Anthelmintic Drugs Market Size by Type (2016-2021)
7.2.2 Europe Injectable Anthelmintic Drugs Market Size by Type (2022-2027)
7.2.3 Europe Injectable Anthelmintic Drugs Market Size by Type (2016-2027)
7.3 Europe Injectable Anthelmintic Drugs Market Size by Application
7.3.1 Europe Injectable Anthelmintic Drugs Market Size by Application (2016-2021)
7.3.2 Europe Injectable Anthelmintic Drugs Market Size by Application (2022-2027)
7.3.3 Europe Injectable Anthelmintic Drugs Market Size by Application (2016-2027)
7.4 Europe Injectable Anthelmintic Drugs Market Size by Country
7.4.1 Europe Injectable Anthelmintic Drugs Market Size by Country (2016-2021)
7.4.2 Europe Injectable Anthelmintic Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size (2016-2027)
8.2 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Type
8.2.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Application
8.3.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region
8.4.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Injectable Anthelmintic Drugs Market Size (2016-2027)
9.2 Latin America Injectable Anthelmintic Drugs Market Size by Type
9.2.1 Latin America Injectable Anthelmintic Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Injectable Anthelmintic Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Injectable Anthelmintic Drugs Market Size by Type (2016-2027)
9.3 Latin America Injectable Anthelmintic Drugs Market Size by Application
9.3.1 Latin America Injectable Anthelmintic Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Injectable Anthelmintic Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Injectable Anthelmintic Drugs Market Size by Application (2016-2027)
9.4 Latin America Injectable Anthelmintic Drugs Market Size by Country
9.4.1 Latin America Injectable Anthelmintic Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Injectable Anthelmintic Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size (2016-2027)
10.2 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Type
10.2.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Application
10.3.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country
10.4.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Novartis Business Overview
11.1.3 Novartis Injectable Anthelmintic Drugs Introduction
11.1.4 Novartis Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
11.1.5 Novartis Recent Development
11.2 Cipla
11.2.1 Cipla Company Details
11.2.2 Cipla Business Overview
11.2.3 Cipla Injectable Anthelmintic Drugs Introduction
11.2.4 Cipla Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
11.2.5 Cipla Recent Development
11.3 Sun Pharmaceutical Industries
11.3.1 Sun Pharmaceutical Industries Company Details
11.3.2 Sun Pharmaceutical Industries Business Overview
11.3.3 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Introduction
11.3.4 Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
11.3.5 Sun Pharmaceutical Industries Recent Development
11.4 Amneal Pharmaceuticals
11.4.1 Amneal Pharmaceuticals Company Details
11.4.2 Amneal Pharmaceuticals Business Overview
11.4.3 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Introduction
11.4.4 Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
11.4.5 Amneal Pharmaceuticals Recent Development
11.5 Zoetis
11.5.1 Zoetis Company Details
11.5.2 Zoetis Business Overview
11.5.3 Zoetis Injectable Anthelmintic Drugs Introduction
11.5.4 Zoetis Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
11.5.5 Zoetis Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Injectable Anthelmintic Drugs Introduction
11.6.4 GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Injectable Anthelmintic Drugs Introduction
11.7.4 Bayer Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
11.7.5 Bayer Recent Development
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Injectable Anthelmintic Drugs Introduction
11.8.4 Merck Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
11.8.5 Merck Recent Development
11.9 Boehringer Ingelheim International
11.9.1 Boehringer Ingelheim International Company Details
11.9.2 Boehringer Ingelheim International Business Overview
11.9.3 Boehringer Ingelheim International Injectable Anthelmintic Drugs Introduction
11.9.4 Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2016-2021)
11.9.5 Boehringer Ingelheim International Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Benzimidazoles
Table 3. Key Players of Piperazine
Table 4. Key Players of Imidazothiazole
Table 5. Key Players of Spiroindoles
Table 6. Key Players of Others
Table 7. Global Injectable Anthelmintic Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Injectable Anthelmintic Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Injectable Anthelmintic Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Injectable Anthelmintic Drugs Market Share by Regions (2016-2021)
Table 11. Global Injectable Anthelmintic Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Injectable Anthelmintic Drugs Market Share by Regions (2022-2027)
Table 13. Injectable Anthelmintic Drugs Market Trends
Table 14. Injectable Anthelmintic Drugs Market Drivers
Table 15. Injectable Anthelmintic Drugs Market Challenges
Table 16. Injectable Anthelmintic Drugs Market Restraints
Table 17. Global Injectable Anthelmintic Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Injectable Anthelmintic Drugs Market Share by Players (2016-2021)
Table 19. Global Top Injectable Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Anthelmintic Drugs as of 2020)
Table 20. Ranking of Global Top Injectable Anthelmintic Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Injectable Anthelmintic Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Injectable Anthelmintic Drugs Product Solution and Service
Table 24. Date of Enter into Injectable Anthelmintic Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Injectable Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Injectable Anthelmintic Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Injectable Anthelmintic Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Injectable Anthelmintic Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Injectable Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Injectable Anthelmintic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Injectable Anthelmintic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Injectable Anthelmintic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Injectable Anthelmintic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Injectable Anthelmintic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Injectable Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Injectable Anthelmintic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Injectable Anthelmintic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Injectable Anthelmintic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Injectable Anthelmintic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Injectable Anthelmintic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Injectable Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Injectable Anthelmintic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Injectable Anthelmintic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Injectable Anthelmintic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Injectable Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Injectable Anthelmintic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Injectable Anthelmintic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Injectable Anthelmintic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Injectable Anthelmintic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Injectable Anthelmintic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Injectable Anthelmintic Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Injectable Anthelmintic Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Injectable Anthelmintic Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Injectable Anthelmintic Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Novartis Company Details
Table 65. Novartis Business Overview
Table 66. Novartis Injectable Anthelmintic Drugs Product
Table 67. Novartis Revenue in Injectable Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 68. Novartis Recent Development
Table 69. Cipla Company Details
Table 70. Cipla Business Overview
Table 71. Cipla Injectable Anthelmintic Drugs Product
Table 72. Cipla Revenue in Injectable Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 73. Cipla Recent Development
Table 74. Sun Pharmaceutical Industries Company Details
Table 75. Sun Pharmaceutical Industries Business Overview
Table 76. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product
Table 77. Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 78. Sun Pharmaceutical Industries Recent Development
Table 79. Amneal Pharmaceuticals Company Details
Table 80. Amneal Pharmaceuticals Business Overview
Table 81. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product
Table 82. Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 83. Amneal Pharmaceuticals Recent Development
Table 84. Zoetis Company Details
Table 85. Zoetis Business Overview
Table 86. Zoetis Injectable Anthelmintic Drugs Product
Table 87. Zoetis Revenue in Injectable Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 88. Zoetis Recent Development
Table 89. GlaxoSmithKline Company Details
Table 90. GlaxoSmithKline Business Overview
Table 91. GlaxoSmithKline Injectable Anthelmintic Drugs Product
Table 92. GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 93. GlaxoSmithKline Recent Development
Table 94. Bayer Company Details
Table 95. Bayer Business Overview
Table 96. Bayer Injectable Anthelmintic Drugs Product
Table 97. Bayer Revenue in Injectable Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 98. Bayer Recent Development
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Revenue in Injectable Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 102. Merck Recent Development
Table 103. Boehringer Ingelheim International Company Details
Table 104. Boehringer Ingelheim International Business Overview
Table 105. Boehringer Ingelheim International Injectable Anthelmintic Drugs Product
Table 106. Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2016-2021) & (US$ Million)
Table 107. Boehringer Ingelheim International Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Injectable Anthelmintic Drugs Market Share by Type: 2020 VS 2027
Figure 2. Benzimidazoles Features
Figure 3. Piperazine Features
Figure 4. Imidazothiazole Features
Figure 5. Spiroindoles Features
Figure 6. Others Features
Figure 7. Global Injectable Anthelmintic Drugs Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Veterinary Pharmacies Case Studies
Figure 12. Others Case Studies
Figure 13. Injectable Anthelmintic Drugs Report Years Considered
Figure 14. Global Injectable Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Injectable Anthelmintic Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Injectable Anthelmintic Drugs Market Share by Regions: 2020 VS 2027
Figure 17. Global Injectable Anthelmintic Drugs Market Share by Regions (2022-2027)
Figure 18. Global Injectable Anthelmintic Drugs Market Share by Players in 2020
Figure 19. Global Top Injectable Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Anthelmintic Drugs as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Injectable Anthelmintic Drugs Revenue in 2020
Figure 21. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2016-2021)
Figure 22. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2022-2027)
Figure 23. North America Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Injectable Anthelmintic Drugs Market Share by Type (2016-2027)
Figure 25. North America Injectable Anthelmintic Drugs Market Share by Application (2016-2027)
Figure 26. North America Injectable Anthelmintic Drugs Market Share by Country (2016-2027)
Figure 27. United States Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Injectable Anthelmintic Drugs Market Share by Type (2016-2027)
Figure 31. Europe Injectable Anthelmintic Drugs Market Share by Application (2016-2027)
Figure 32. Europe Injectable Anthelmintic Drugs Market Share by Country (2016-2027)
Figure 33. Germany Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Injectable Anthelmintic Drugs Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Injectable Anthelmintic Drugs Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Injectable Anthelmintic Drugs Market Share by Region (2016-2027)
Figure 43. China Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Injectable Anthelmintic Drugs Market Share by Type (2016-2027)
Figure 51. Latin America Injectable Anthelmintic Drugs Market Share by Application (2016-2027)
Figure 52. Latin America Injectable Anthelmintic Drugs Market Share by Country (2016-2027)
Figure 53. Mexico Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Injectable Anthelmintic Drugs Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Injectable Anthelmintic Drugs Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Injectable Anthelmintic Drugs Market Share by Country (2016-2027)
Figure 59. Turkey Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Injectable Anthelmintic Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Novartis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2016-2021)
Figure 63. Cipla Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2016-2021)
Figure 64. Sun Pharmaceutical Industries Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2016-2021)
Figure 65. Amneal Pharmaceuticals Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2016-2021)
Figure 66. Zoetis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2016-2021)
Figure 67. GlaxoSmithKline Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2016-2021)
Figure 68. Bayer Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2016-2021)
Figure 69. Merck Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2016-2021)
Figure 70. Boehringer Ingelheim International Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の高分子注射薬市場規模・現状・予測（2021年-2027年）

Global Large Molecule Injectable Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4411 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、高分子注射薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（静脈注射、筋肉注射、皮下注射）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界の注射式鎮痛薬市場規模・現状・予測（2021年-2027年）

Global Injectable Pain Medication Market Size, Status and Forecast 2021-2027
QFJ1-4373 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、注射式鎮痛薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬（NSAID）、中枢作用性鎮痛薬）、用途別市場規模（病院、クリニック、リカバリーセンター）、主要地域別市場規模（北米、...

世界の注射式標的治療市場規模・現状・予測（2021年-2027年）

Global Injectable Targeted Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4374 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、注射式標的治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、小分子、免疫毒素、その他）、用途別市場規模（病院、在宅医療、専門クリニック、その他）、主要地域別市場規模（北米、アメリ...

世界の注射式しわ治療市場規模・現状・予測（2021年-2027年）

Global Injectable Anti-Wrinkle Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4372 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、注射式しわ治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（筋弛緩薬、ヒアルロン酸リンクルフィラー、合成リンクルフィラー、コラーゲンリンクルフィラー、自己リンクルフィラー）、用途別市場規模（男性用、...

世界の注射式骨代替物市場規模・現状・予測（2021年-2027年）

Global Injectable Bone Substitute Market Size, Status and Forecast 2021-2027
QFJ1-5213 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、注射式骨代替物の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（天然、合成）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、...

世界の長時間作用型注射薬市場規模・現状・予測（2021年-2027年）

Global Long-acting Injectable Medications Market Size, Status and Forecast 2021-2027
QFJ1-4439 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、長時間作用型注射薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（第一世代、第二世代）、用途別市場規模（統合失調症、避妊、HIV、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界の神経調節物質注射市場規模・現状・予測（2021年-2027年）

Global Neuromodulators Injectable Market Size, Status and Forecast 2021-2027
QFJ1-4570 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、神経調節物質注射の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ボツリヌス毒素、ヒアルロン酸、ヒドロキシアパタイトカルシウム、ポリ-L-乳酸、その他）、用途別市場規模（病院、皮膚科クリニック、スパ、エ...

世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年）

Global Non Insulin Anti diabetes Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4583 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、インスリン非依存型糖尿病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

世界の肥満細胞腫治療薬市場規模・現状・予測（2021年-2027年）

Global Mast Cell Tumor Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4463 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、肥満細胞腫治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（外用薬、経口薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界の化学療法誘発性血小板減少症治療薬市場規模・現状・予測（2021年-2027年）

Global Chemotherapy Induced Thrombocytopenia Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3999 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、化学療法誘発性血小板減少症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア...

世界の高分子注射薬市場規模・現状・予測（2021年-2027年） Large molecules (biologics), also called biopharmaceuticals, are a type of drugs. These are based on proteins which have a therapeutic effect. Market Analysis and Insights: Global Large Molecule Injectable Drugs Market The global Large Molecule Injectable Drugs market size is projected to reach US$ …
世界の調剤薬局市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Compounding Pharmacies Market The global Compounding Pharmacies market size is projected to reach US$ 13500 million by 2027, from US$ 11180 million in 2020, at a CAGR of 2.7% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, t…
世界のモノクローナル抗体滅菌注射薬産業調査2019-2025 Monoclonal antibodies are produced through cell division from a single ancestral or parent cell.In 2018, the global Monoclonal Antibodies Sterile Injectable Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been…
世界のモノクローナル抗体滅菌注射薬産業調査2019-2025 Monoclonal antibodies are produced through cell division from a single ancestral or parent cell.In 2018, the global Monoclonal Antibodies Sterile Injectable Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been…
世界のインスリン非依存型糖尿病治療薬市場規模・現状・予測（2021年-2027年） Diabetes is a metabolic disease, wherein the body is either unable to secret insulin (type 1 diabetes) or is unable to utilize the generated insulin (type 2 diabetes). Market Analysis and Insights: Global Non Insulin Anti diabetes Drugs Market The global Non Insulin Anti diabetes Drugs market size i…